| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785437 | Brachytherapy | 2017 | 10 Pages |
Abstract
4-8wkPSA is a novel predictor of bFFS for patients receiving LDR-BT across several risk categories and treatment regimens with potential clinical utility as a prognostic indicator. Certain comorbidities and exposure histories also demonstrated significant relationships with bFFS including chronic obstructive pulmonary disease, diabetes mellitus, age, alcohol history, proton pump inhibitor use, PSA nadir, and PSA density.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Cameron M. Callaghan, Lin Wang, Abhishek Alluri, Andrew Lauve, Cynthia Boyer, William Russell,